{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:37:27Z","timestamp":1792255047952,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-021790"],"award-info":[{"award-number":["INV-021790"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ijgc-2022-004197","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T10:55:12Z","timestamp":1678704912000},"page":"802-811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Quality assurance in human papillomavirus testing for primary cervical screening"],"prefix":"10.1016","volume":"33","author":[{"given":"Kate","family":"Cuschieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Fellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-5206","authenticated-orcid":false,"given":"Laila Sara","family":"Arroyo M\u00fchr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Padalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Mariel","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-4459","authenticated-orcid":false,"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alejandra","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-004197_bb0010","author":"World Health Organization W","year":"2022","journal-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem"},{"key":"10.1136\/ijgc-2022-004197_bb0015","author":"World Health Organization","year":"2021"},{"key":"10.1136\/ijgc-2022-004197_bb0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-004197_bb0025","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30 Suppl 5","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2022-004197_bb0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-004197_bb0035","author":"Paul","year":"2021"},{"key":"10.1136\/ijgc-2022-004197_bb0040","unstructured":"WHO . WHO laboratory quality management. n.d.Available: https:\/\/www.who.int\/activities\/laboratory-quality-management"},{"key":"10.1136\/ijgc-2022-004197_bb0045","article-title":"Chapter 23: international standard reagents for harmonization of HPV serology and DNA assays -- an update","volume":"24 Suppl 3","author":"Pagliusi","year":"2006","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2022-004197_bb0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vaccine.2008.10.062","article-title":"WHO meeting on the standardization of HPV assays and the role of the WHO HPV laboratory network in supporting vaccine introduction held on 24-25 january 2008, geneva, switzerland","volume":"27","author":"Ferguson","year":"2009","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2022-004197_bb0055","unstructured":"International HPV Reference Center . International HPV reference center. n.d.Available: https:\/\/ki.se\/en\/labmed\/international-hpv-reference-center"},{"key":"10.1136\/ijgc-2022-004197_bb0060","first-page":"1","author":"IARC","year":"2022","journal-title":"Cervical cancer screening. IARC handb cancer prev, vol 18"},{"key":"10.1136\/ijgc-2022-004197_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens -- part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2022-004197_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","article-title":"2020 list of human papillomavirus assays suitable for primary cervical cancer screening","volume":"27","author":"Arbyn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1136\/ijgc-2022-004197_bb0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-004197_bb0080","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","article-title":"Commercially available molecular tests for human papillomaviruses: a global overview","volume":"26","author":"Poljak","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1136\/ijgc-2022-004197_bb0085","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76 Suppl 1","author":"Arbyn","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2022-004197_bb0090","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JCM.00897-16","article-title":"Performance of a cartridge-based assay for detection of clinically significant human papillomavirus (HPV) infection: lessons from VALGENT (validation of HPV genotyping tests)","volume":"54","author":"Cuschieri","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1136\/ijgc-2022-004197_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cyt.12679","article-title":"Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing","volume":"30","author":"Cuschieri","year":"2019","journal-title":"Cytopathology"},{"key":"10.1136\/ijgc-2022-004197_bb0100","doi-asserted-by":"crossref","first-page":"104756","DOI":"10.1016\/j.jcv.2021.104756","article-title":"The challenges of defining sample adequacy in an era of HPV based cervical screening","volume":"137","author":"Cuschieri","year":"2021","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2022-004197_bb0105","unstructured":"ISO . International organization for standardization; Available: https:\/\/www.iso.org"},{"key":"10.1136\/ijgc-2022-004197_bb0110","unstructured":"ISO 15189: 2012 medical laboratories-requirements for quality and competence . n.d.Available: https:\/\/www.iso.org\/standard\/56115.html"},{"key":"10.1136\/ijgc-2022-004197_bb0115","unstructured":"ISO 17025:2017- general requirement for the competence of testing and calibrations laboratories . n.d.Available: https:\/\/www.iso.org"},{"key":"10.1136\/ijgc-2022-004197_bb0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.31080\/ASMI.2020.03.quality-control-and-assurance-in-iso151892012-molecular-cytopathology-laboratories-for-hpv-dna-testing","article-title":"Quality control and assurance in ISO15189:2012 molecular cytopathology laboratories for HPV DNA testing","volume":"3","author":"Vavoulidis","year":"2020","journal-title":"Acta Scientific Microbiology"},{"key":"10.1136\/ijgc-2022-004197_bb0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/jomb-2017-0025","article-title":"Accreditation of medical laboratories-system, process, benefits for labs","volume":"36","author":"Zima","year":"2017","journal-title":"J Med Biochem"},{"key":"10.1136\/ijgc-2022-004197_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-2004-4_6","article-title":"Validation of molecular diagnostic assays and quality assurance and control in the veterinary laboratory","volume":"1247","author":"Saunders","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1136\/ijgc-2022-004197_bb0135","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2015.10.025","article-title":"HPV testing for primary cervical screening: laboratory issues and evolving requirements for robust quality assurance","volume":"76 Suppl 1","author":"Carozzi","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2022-004197_bb0140","unstructured":"NHS Cervical Screening Programme . Laboratory quality control and assurance for human papillomavirus testing; Available: https:\/\/www.gov.uk\/government\/publications\/cervical-screening-laboratory-testing-for-human-papillomaviru [Accessed 27 Sep 2022]."},{"key":"10.1136\/ijgc-2022-004197_bb0145","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/ijc.33769","article-title":"Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program","volume":"149","author":"Hortlund","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-004197_bb0150","unstructured":"Guidance on classification rules for in-vitro diagnostic medical devices for regulation (EU) 2017\/746. N.d Available: https:\/\/health.ec.europa.eu\/"},{"key":"10.1136\/ijgc-2022-004197_bb0155","unstructured":"University of Oxford . Introduction to good clinical laboratory practice; Available: https:\/\/globalhealthtrainingcentre.tghn.org\/good-clinical-laboratory-practice\/ [Accessed 27 Sep 2022]."},{"key":"10.1136\/ijgc-2022-004197_bb0160","unstructured":"Quality Control for Molecular Diagnostics . Quality control for molecular diagnostics; Available: https:\/\/www.qcmd.org [Accessed 19 Sep 2022]."},{"key":"10.1136\/ijgc-2022-004197_bb0165","unstructured":"College of American Pathologists . n.d.Available: https:\/\/cap.org"},{"key":"10.1136\/ijgc-2022-004197_bb0170","unstructured":"HPV center . n.d.Available: www.hpvcenter.se\/proficiency_panel"},{"key":"10.1136\/ijgc-2022-004197_bb0175","unstructured":"QuIP . Available: https:\/\/qualityinpathology.com [Accessed 19 Sep 2022]."},{"key":"10.1136\/ijgc-2022-004197_bb0180","unstructured":"UK NEQAS for microbiology . Available: https:\/\/ukneqasmicro.org.uk [Accessed 19 Sep 2022]."},{"key":"10.1136\/ijgc-2022-004197_bb0185","unstructured":"EQAS . n.d.Labquality. Available: https:\/\/labquality.fi"},{"key":"10.1136\/ijgc-2022-004197_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1515\/cclm-2016-0293","article-title":"External quality assessment for human papillomavirus 16\/18 DNA detection and genotyping in Shanghai, China","volume":"55","author":"Wang","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1136\/ijgc-2022-004197_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-2028-7","article-title":"Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study","volume":"16","author":"Enges\u00e6ter","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1136\/ijgc-2022-004197_bb0200","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pathol.2018.05.005","article-title":"Development of a pilot proficiency program for human papillomavirus DNA detection","volume":"50","author":"Costa","year":"2018","journal-title":"Pathology"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24024125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-004197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:40:05Z","timestamp":1753101605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24024125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1048891X24024125"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-004197","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality assurance in human papillomavirus testing for primary cervical screening","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-004197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https:\/\/creativecommons.org\/licenses\/by\/4.0\/.","name":"copyright","label":"Copyright"}]}}